Pages that link to "Q72920932"
Jump to navigation
Jump to search
The following pages link to Inhibition of separated forms of cyclic nucleotide phosphodiesterase from pig coronary arteries by 1,3-disubstituted and 1,3,8-trisubstituted xanthines (Q72920932):
Displaying 14 items.
- X-ray Structures of two xanthine inhibitors bound to PEPCK and N -3 modifications of substituted 1,8-Dibenzylxanthines (Q27642333) (← links)
- Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation (Q33906531) (← links)
- Alkylxanthines as research tools (Q33907103) (← links)
- Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes (Q34305874) (← links)
- Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells (Q35750809) (← links)
- ADH resistance of LLC-pk1 cells caused by overexpression of cAMP-phosphodiesterase type-IV. (Q41549700) (← links)
- Epidermal growth factor potentiates cyclic AMP accumulation in A-431 cells (Q41725363) (← links)
- Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some pentasubstituted quercetin analogs (Q42245855) (← links)
- Towards a standard method to demonstrate adenylate cyclase activity at the electron microscopical level (Q42477047) (← links)
- Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine (Q42847426) (← links)
- Caffeine analogs: effects on ryanodine-sensitive calcium-release channels and GABAA receptors (Q44490771) (← links)
- Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase (Q67669457) (← links)
- Selective inhibition by NPT 15392 of lymphocyte cyclic GMP phosphodiesterase (Q72400644) (← links)
- Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV (Q72735569) (← links)